For Japanese investors
Disclaimer
The information in the presentations on these pages was factually accurate on the date of publication.
These presentations remain on the Novartis website for historical purposes only.
Novartis assumes no duty to update the information to reflect subsequent developments.
Readers should not rely upon the information in these pages as current or accurate after their publication dates.
- 2011 Full Year Result
Joseph Jimenez, Chief Executive Officer
Jon Symonds, Chief Financial Officer
David Epstein, Division Head, Novartis Pharmaceuticals
Kevin Buehler, Division Head, Alcon
Jeff George, Division Head, Sandoz
English / Japanese
3,0 MB - 2010 Full Year Result
Jon Symonds, Chief Financial Officer
David Epstein, Division Heah, Novartis PharmaceuticalsEnglish / Japanese
4,0 MB - 2009 Full Year Result
Daniel Vasella, M.D. Chairman and Chief Executive Officer
Raymund Breu, Ph.D. Chief Financial Officer
Joe Jimenez, Head of PharmaceuticalsEnglish / Japanese
1,7 MB
- Novartis investor event - December 9, 2009
Novartis Pharmaceuticals: Separating from the pack
Joe Jimenez, CEO Novartis PharmaceuticalsEnglish / Japanese
1.05 MBDevelopment Update
Trevor Mundel, Global Head of DevelopmentEnglish / Japanese
1.47 MBNovartis Oncology – Leadership in cancer and hematology that changes patients’ lives
David Epstein, President and CEO Novartis Oncology and Novartis Molecular DiagnosticsEnglish / Japanese
650 KBOncology Translational Medicine
Barbara L. Weber, M.D., SVP, Oncology Translational MedicineEnglish / Japanese
1.29 MBThe NET Opportunity
James Yao, M.D. - Associate Professor and Deputy Chair, Gastrointestinal Medical Oncology - University of Texas M. D. Anderson Cancer Center Vice chair, North American Neuroendocrine Tumor Society (NANETs)English / Japanese
2.94 MBOncology Global Development
Alessandro Riva, M.D, EVP and Global Head Development, OncologyEnglish / Japanese
1.20 MBCommercial Strategy and Performance
Herve Hoppenot, Executive Vice President, Chief Commercial OfficerEnglish / Japanese
1.49 MBNovartis Oncology – Leadership in cancer and hematology that changes patients’ lives
David Epstein, President and CEO, Novartis Oncology and Novartis Molecular DiagnosticsEnglish / Japanese
571 KB
